Shrimp Disease Diagnostics Market Size, Share, Growth, and Industry Growth By Type (WSSV, TSV, YHV/GAV, IHHNV, HPV, MBV (Monodon Baculo virus), IMNV (Infectious Myonecrosis Virus), NHP-B (Necrotising Hepatopancreatitis Bacteria and others) By Application (fisherise, aquaculature laboratories, education and research institute and others) regional forecast From 2025 To 2034

Last Updated: 11 August 2025
SKU ID: 30051304

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

SHRIMP DISEASE DIAGNOSTICS MARKET OVERVIEW

The global Shrimp Disease Diagnostics Market size stood at USD 0.21 billion in 2025, growing further to USD 0.62 billion by 2034 at an estimated CAGR of 12.58% from 2025 to 2034.

The United States Shrimp Disease Diagnostics Market size is projected at USD 0.00749 billion in 2025, the Europe Shrimp Disease Diagnostics Market size is projected at USD 0.00662 billion in 2025, and the China Shrimp Disease Diagnostics Market size is projected at USD 0.06552 billion in 2025.

Increased demand for shrimp for human consumption coupled with growing demand for marine & freshwater farming is the major factor of the market growth. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel market growth in the forthcoming years. Further, a rise in awareness of diseases associated with shrimp and digestion problems is anticipated to foster market progress. The growing need for DNA-based diagnostic tools such as PCR and the rapid adoption of technology in the marine and aqua sectors is projected to expand market growth. In addition, the easy availability of test kits in the pharmaceutical is expected to drive market growth. On the contrary, the high cost associated with disease diagnostic technology is predicted to restrict market growth in the forthcoming years.  

KEY FINDINGS

  • Market Size and Growth: USD 0.21 billion in 2025, growing further to USD 0.62 billion by 2034 at an estimated CAGR of 12.58% from 2025 to 2034.
  • Key Market Driver: over 55% of global shrimp farms have adopted early disease detection methods to prevent mass mortality events.
  • Major Market Restraint: 37% of shrimp-producing regions, particularly small-scale farms, face affordability issues in accessing molecular diagnostic tools.
  • Emerging Trends: PCR-based technologies accounted for over 45% share of diagnostic methods in 2024, while LAMP techniques held about 32%.
  • Regional Leadership:Asia‑Pacific region holds nearly 60% of market share, with India and Vietnam alone representing about 48% of regional demand.
  • Competitive Landscape: leading market players include SHANSHIBIO Lab - Ind Resource Sdn Bhd. Genics SUREBIO GeneReach Biotechnology Corp. BiOptic Inc Nusantics.
  • Market Segmentation: around 60% of market share by type, with WSSV at 45% and TSV at 30%.
  • Recent Development: September 2018 SUREBIO introduced the GenePasQ DNA Shrimp Disease Test Kit in Southeast Asia.

 

COVID-19 IMPACT

Lack of Fishermen due to Lockdown Restrictions to Harm Market Growth 

Closure of manufacturing units and lower demand for the technology due to lockdown restrictions. The shutdown of marine and aquaculture laboratories and the lack of fishers due to health safety restrict the market growth.

LATEST TRENDS

Increased Demand for Seafood Globally to Push Market Growth

Increasing demand for seafood globally is estimated to fuel market growth. A rise in awareness about the benefits of seafood in diet coupled with a high need for a nutritious diet is predicted to surge market growth. Huge demand for protein-based dirt for muscle gain and an increased number of dietitians refer to seafood for high protein and other several nutritional properties. These factors are estimated to boost technology adoption in the forthcoming years. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel shrimp diseases diagnostics market market growth.

  • point‑of‑care diagnostic kits represent around 35% of total market demand, with over 48% of emerging‑market shrimp farmers using them for onsite testing.
  • Implementation of biosecurity measures has increased by 40% globally, driving consistent demand for routine diagnostic testing.

SHRIMP DISEASE DIAGNOSTICS MARKET SEGMENTATION

By Type

Based on type, the market is divided into WSSV (White Spot Syndrome Virus), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill Associated Virus), IHHNV (Infectious Hypodermal and Hematopoietic Virus), HPV (Hepatopancreatic Parvovirus), EMS (Early Mortality Syndrome), EHP (Enterocytozoon hepatopenaei), Others.

WSSV (White Spot Syndrome Virus) is expected to be the top part of the segmentation type.

By Application

Based on the application, the market is divided into Fisheries, Aquaculture Laboratories, Marine Laboratories, Education and Research Institutes, Others.

DRIVING FACTORS

Growing need for Shrimp Farming and Huge Production of Shrimps to Surge Market Growth

Increasing demand for shrimp globally and huge production of shrimp are anticipated to drive market growth.  A rise in demand for technology in education and research institutes is projected to contribute to market growth. Increased need to reduce disease prevalence and huge adoption of technology is predicted to surge market growth. Increased spending capacity and growing awareness about health safety are anticipated to accelerate market progress in the forthcoming years. Increased demand for freshwater and marine shrimp farming is expected to fuel market progress.

Increased Prevalence of Viral Infections in Shrimps to Foster Market Progress

The growing prevalence of viral infection in shrimps and the high need to detect to control spreading is estimated to fuel market growth. Huge demand to detect shrimp disease and a growing need to improve marine farming methods is anticipated to drive market growth.  An increased number of manufacturers are focused on developing PCR base systems and ensuring flexible & real is estimated to drive market growth in the forthcoming years.

  • Over 65% of global shrimp supply originates from intensive aquaculture systems that depend heavily on diagnostics.
  • Viral infections account for over 60% of disease‑related shrimp mortality, prompting greater demand for pathogen detection tools

RESTRAINING FACTORS

High Cost of the Technology to Harm Market Progress

The high cost associated with disease diagnostic technology is predicted to restrict market growth in the forthcoming years. 

  • Only around 42% of small‑scale farmers can afford advanced molecular diagnostic tools, limiting wider penetration.
  • Approximately 38% of shrimp farmers lack familiarity with advanced diagnostic methods, with training coverage below 42% in rural areas

SHRIMP DISEASE DIAGNOSTICS MARKET REGIONAL INSIGHTS

High Production Rate in Asia Pacific to Drive Market Share

Asia Pacific is anticipated to dominate the shrimp disease diagnostics market share owing to the high production rate in India and China. Increased government regulation for food safety and huge consumption of shrimp’s consumption. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel market growth in the forthcoming years. Further, a rise in awareness of diseases associated with shrimp and digestion problems is anticipated to foster market progress. The growing need for DNA-based diagnostic tools such as PCR and the rapid adoption of technology in the marine and aqua sectors is projected to expand market growth.

KEY INDUSTRY PLAYERS

Leading Players Adopt New Strategies to Stay Competitive

The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

  • SHANSHIBIO: Recognized in industry reports as a niche provider focusing on rapid assay kits.
  • Lab‑Ind Resource Sdn Bhd.: Listed as a major player in multiple offering assay‑based diagnostics tailored for shrimp pathogens

List of Top Shrimp Disease Diagnostics Companies

  • SHANSHIBIO
  • Lab - Ind Resource Sdn Bhd.
  • Genics
  • SUREBIO
  • GeneReach Biotechnology Corp.
  • BiOptic Inc
  • Nusantics
  • Thermo Fisher Scientific
  • HiMedia Laboratories
  • AquaSol, Inc.
  • Auro Biotechnologies
  • Speedy Assay Sd??n Bhd

REPORT COVERAGE

This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.

Shrimp Disease Diagnostics Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 0.21 Billion in 2025

Market Size Value By

US$ 0.62 Billion by 2034

Growth Rate

CAGR of 12.58% from 2025 to 2034

Forecast Period

2025-2034

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • WSSV (White Spot Syndrome Virus)
  • TSV (Taura Syndrome Virus)
  • YHV/GAV (Yellow Head/Gill Associated Virus)
  • IHHNV (Infectious Hypodermal and Hematopoietic Virus)
  • HPV (Hepatopancreatic Parvovirus)
  • EMS (Early Mortality Syndrome)
  • EHP (Enterocytozoon hepatopenaei)
  • Others

By Application

  • Fisheries
  • Aquaculture Laboratories
  • Marine Laboratories
  • Education and Research Institutes
  • Others

FAQs